SB 1428 creates the Office of Alzheimer’s Disease and Related Dementia Service Coordination within Oklahoma’s State Department of Health, effective November 1, 2026. The office will coordinate statewide dementia services, eliminate duplicated efforts, collect data, support staff training, and identify grant opportunities to improve care for individuals with Alzheimer’s or related dementias and their caregivers. It requires the office to maintain a full-time dementia services coordinator position to manage operations. The bill repeals two outdated sections of Oklahoma law (63 O.S. 2021, Sections 1-879.2 and 1-879.3) related to dementia services.
HB 1168 makes it a felony to knowingly deliver or possess abortion-inducing drugs (like misoprostol or methotrexate) with the intent of causing an abortion, punishable by up to $100,000 in fines or 10 years in prison. It directly affects individuals who provide such drugs for non-exceptional purposes, including off-label use for abortion. Key exceptions include pharmacists, manufacturers, and distributors acting within lawful medical practices, as well as preventive contraception used as directed by manufacturers. The law does not restrict treatment for ectopic pregnancies, miscarriages, or medical uses of drugs like chemotherapy.
SB 1255 requires Oklahoma's Department of Corrections medical director to certify qualifying medical conditions and request the Pardon and Parole Board to place eligible inmates on a special docket for compassionate parole consideration. It directly affects inmates with specific terminal or debilitating conditions like dementia, cancer, HIV/AIDS, or conditions causing near-death (six-month life expectancy), or those unable to perform basic self-care. The bill bypasses the standard two-step parole hearing process for these inmates and mandates that at least three Board members must concur to consider medical parole. The Board must document concurrence in meeting minutes, and parolees may face revocation if their medical condition poses public safety risks.
HB 3143 extends Oklahoma's moratorium on new medical marijuana business licenses (dispensaries, processors, growers) from August 1, 2026, to August 1, 2028. It requires existing license holders to get written approval from the Oklahoma Medical Marijuana Authority before transferring ownership, including submitting documentation to the Oklahoma State Bureau of Narcotics. Transfers must follow a 15-business-day timeline for license and registration changes, and applicants cannot submit transfer requests if disciplinary actions are pending. The bill also mandates that businesses provide a full inventory of all medical marijuana products during ownership changes and prohibits transfers without approval, with a 30-day window for pending applications to comply with new rules.
SB 1344 creates Oklahoma's Insulin Access and Affordability Program, administered by the State Department of Health, to increase access to affordable insulin for residents. The bill requires the Department to provide financial support to a nonprofit pharmaceutical manufacturer developing fast-acting biosimilar insulin, contingent on the manufacturer matching funds and agreeing to produce insulin at low cost without rebates (except as required by law). The agreement includes annual reporting on development progress and repayment terms if the insulin isn't produced and distributed as promised. This program directly affects Oklahoma residents needing insulin, public and private payors, and the specified nonprofit manufacturer.
SB 1134 allocates $100,000 from Oklahoma's General Revenue Fund to the Oklahoma Health Care Authority for the 2026 fiscal year. The bill directly provides funding for the Authority to carry out its legal duties. It declares an emergency to allow immediate implementation upon passage. This is a procedural appropriations measure with no policy changes beyond the specified funding amount.
SB 1142 allocates $100,000 from unallocated state funds to Oklahoma's Department of Mental Health and Substance Abuse Services for the 2025-2026 fiscal year. The funding is intended to support the department's existing duties, including providing mental health and substance abuse services to Oklahomans. The bill declares an emergency to allow immediate implementation upon approval, bypassing standard legislative timelines. This is a procedural funding measure, not a policy change, and remains pending before the Appropriations Committee.
HB 3127 protects Oklahoma medical marijuana patients and caregivers from discrimination in employment, public assistance, and firearm ownership. It prohibits employers from refusing to hire, firing, or penalizing individuals solely for being a licensed medical marijuana user, and bars denial of Medicaid, SNAP, or firearm rights based on that status. However, the bill mandates a "zero-tolerance" policy for safety-sensitive jobs (like operating vehicles, handling hazardous materials, or direct patient care), allowing employers to enforce drug testing and discipline for marijuana use at work. Employers may still maintain written drug testing policies under state standards, but cannot deny employment based solely on medical marijuana license status or a positive test if the user is licensed and not impaired at work.
HB 3901 establishes a pilot program for psychological autopsies in Oklahoma, which investigate ambiguous deaths (like suicides) to reconstruct a deceased person's mental state and influences. The Commissioner of Health must appoint a full-time psychological autopsy examiner who will submit annual progress reports and coordinate with mental health and medical examiner offices. The pilot runs until November 1, 2031, with a recommendation for permanency or termination. Its goal is to use data from these reviews to inform suicide prevention efforts, without changing existing laws or creating new obligations for individuals.
HB 3194 protects Oklahoma pregnancy centers from state mandates requiring them to provide abortion services, contraception, or referrals. The bill prohibits state agencies from forcing centers to offer abortion-inducing drugs, post promotional materials for abortion, restrict services based on their pro-life stance, or interfere with their staffing decisions. It also allows centers to sue for triple damages (minimum $10,000) if state agencies violate these provisions. The law directly affects pregnancy centers - both general and medical - and state agencies that might attempt to impose such requirements. It focuses on preventing government compulsion, not restricting abortion access.
